Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Microbiome in Immune-Mediated Uveitis.
Int J Mol Sci. 2022 Jun 24;23(13):7020. doi: 10.3390/ijms23137020.
Int J Mol Sci. 2022.
PMID: 35806031
Free PMC article.
Review.
Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review.
Busto-Iglesias M, Rodríguez-Martínez L, Rodríguez-Fernández CA, González-López J, González-Barcia M, de Domingo B, Rodríguez-Rodríguez L, Fernández-Ferreiro A, Mondelo-García C.
Busto-Iglesias M, et al.
Pharmaceutics. 2023 Feb 25;15(3):766. doi: 10.3390/pharmaceutics15030766.
Pharmaceutics. 2023.
PMID: 36986627
Free PMC article.
Review.
Item in Clipboard
Clinical research in hospital pharmacy during the fight against COVID-19.
Castro-Balado A, Varela-Rey I, Bandín-Vilar EJ, Busto-Iglesias M, García-Quintanilla L, Mondelo-García C, Fernández-Ferreiro A.
Castro-Balado A, et al. Among authors: busto iglesias m.
Farm Hosp. 2020 Jun 13;44(7):66-70. doi: 10.7399/fh.11494.
Farm Hosp. 2020.
PMID: 32533675
English.
Item in Clipboard
Drug-related problems as reason for emergency department visit: 3 years of the FARM-URG registry.
Ruiz-Ramos J; GRUPO REDFASTER-SEFH.
Ruiz-Ramos J, et al.
Int J Pharm Pract. 2023 Jun 30;31(4):417-422. doi: 10.1093/ijpp/riad022.
Int J Pharm Pract. 2023.
PMID: 37029923
Item in Clipboard
Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection.
Castro-Balado A, Mondelo-García C, Barbosa-Pereira L, Varela-Rey I, Novo-Veleiro I, Vázquez-Agra N, Antúnez-López JR, Bandín-Vilar EJ, Sendón-García R, Busto-Iglesias M, Rodríguez-Bernaldo de Quirós A, García-Quintanilla L, González-Barcia M, Zarra-Ferro I, Otero-Espinar FJ, Rey-Bretal D, Lago-Quinteiro JR, Valdés-Cuadrado L, Rábade-Castedo C, Del Río-Garma MC, Crespo-Diz C, Delgado-Sánchez O, Aguiar P, Barbeito-Castiñeiras G, Pérez Del Molino-Bernal ML, Trastoy-Pena R, Passannante R, Llop J, Pose-Reino A, Fernández-Ferreiro A.
Castro-Balado A, et al. Among authors: busto iglesias m.
Pharmaceutics. 2021 Mar 5;13(3):342. doi: 10.3390/pharmaceutics13030342.
Pharmaceutics. 2021.
PMID: 33808025
Free PMC article.
Item in Clipboard
Cite
Cite